Atlas Arteria stock analysis
Atlas Arteria (MAQAF) Stock Price & Analysis
MAQAF Stock Chart & Stats
- Day’s Range
- $2.60 - $2.60
- 52-Week Range
- $2.39 - $4.09
- Previous Close
- $2.53
- Volume
- N/A
- Average Volume (3M)
- 155
- Market Cap
- $3.65B
- Enterprise Value
- $8.79B
- Total Cash (Recent Filing)
- $214.00M
- Total Debt (Recent Filing)
- $1.61B
- Price to Earnings (P/E)
- 19.8
- Beta
- 0.17
- Next Earnings
- Feb 24, 2027 (Est.)
- EPS Estimate
- 0.11
- Last Dividend Ex-Date
- Sep 24, 2026
- Dividend Yield
- 9.86%
Bulls Say, Bears Say
Bulls Say
Stronger Cash Generation
The sharp improvement in operating and free cash flow indicates better cash conversion and greater internal funding capacity. If sustained, this supports debt servicing, distributions, and reinvestment in long-life concessions while reducing reliance on external financing.
Improving Underlying Profitability
Underlying profit growth, supported by modest constant-currency revenue and EBITDA gains, suggests the concession portfolio is producing resilient operating results. This provides a stronger earnings base for the next several quarters, despite reported currency effects and exceptional costs.
Manageable Leverage And Liquidity
Moderate and improving leverage, alongside a substantial equity base, gives Atlas Arteria useful financial resilience for infrastructure operations. Stronger liquidity and financing access can support obligations and asset management through traffic or earnings volatility.
Bears Say
Weak Underlying Operating Consistency
Persistent EBIT weakness and wide margin swings indicate that reported bottom-line profit does not consistently reflect stable operating earnings. This makes future cash generation and distribution capacity more dependent on non-operating items and period-specific cost outcomes.
Governance And Growth-path Uncertainty
The ownership transition and paused brownfield expansion reduce visibility on strategic direction and future asset growth. Withdrawal of longer-term distribution targets also makes capital allocation and payout expectations less predictable beyond the current guidance period.
Currency And Traffic Exposure
Atlas Arteria’s international concessions expose reported results to currency movements, while weaker traffic in parts of the portfolio can pressure revenue. These factors can persist across reporting periods and complicate assessment of underlying operating growth.
Atlas Arteria News
MAQAF FAQ
What was Atlas Arteria’s price range in the past 12 months?
What is Atlas Arteria’s market cap?
When is Atlas Arteria’s upcoming earnings report date?
How were Atlas Arteria’s earnings last quarter?
Is Atlas Arteria overvalued?
Does Atlas Arteria pay dividends?
What is Atlas Arteria’s EPS estimate?
How many shares outstanding does Atlas Arteria have?
What happened to Atlas Arteria’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Atlas Arteria?
What is the TipRanks Smart Score and how is it calculated?
Atlas Arteria Stock Smart Score
Company Description
Atlas Arteria
Atlas Arteria Limited specializes in the acquisition, development, and management of toll road assets. Among its key holdings is a 13.4% equity stake in Toll Road Investors Partnership II (TRIP II), the concessionaire responsible for the 22-kilometer Dulles Greenway toll road, situated in Virginia, United States. The company was established in 2009 and operates from its corporate headquarters in Melbourne, Australia. It formally rebranded from Macquarie Atlas Roads Limited to its current name, Atlas Arteria Limited, in May 2018.
- Sector
- Industrials
- Industry
- Industrial - Infrastructure Operations
- CEO
- Hugh Wehby DipInvRel
- Employees
- 50
- Website
- www.atlasarteria.com
- Address
- 180 Flinders Street, Melbourne, VIC, 3000, AU
Atlas Arteria (MAQAF) Earnings & Revenues
MAQAF Company Deck
MAQAF Earnings Call
Earnings Call SentimentNeutral
The call presented a mixed picture. Operationally the portfolio showed resilience — underlying NPAT rose 29%, constant-currency revenue and EBITDA were marginally positive, Dulles and Chicago traffic grew, APRR issued EUR 500m of bonds, and the company maintained its $0.40 distribution guidance while strengthening liquidity. Offsetting this were sizable one-off non-operating charges (put option accounting and settlement, takeover and change-of-control costs), adverse FX translating to a ~3.9% revenue and ~3.6% EBITDA decline in AUD terms, a TRIP bond downgrade, and governance/ownership uncertainty following IFM increasing its stake to ~67%. Overall the operational positives are meaningful but balanced by significant near-term headwinds and one-off costs, leaving the tone cautiously neutral.
View all MAQAF earnings summariesMAQAF Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 7 | 5 | 10 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 4 | 0 | 8 |








